The possibility of eliminating blinding trachoma.
Global elimination of blinding trachoma, the world's leading preventable cause of blindness, now seems possible. The disease, which persists most severely in the poorest parts of Africa and Asia, is already eliminated in North America and Europe. On a scientific basis, the case for elimination was outlined at a WHO global scientific meeting in 1996. To facilitate action, WHO founded the Alliance for Global Elimination of Trachoma by 2020 (GET 2020) in 1997. In 1998 a World Health Assembly resolution called for member states to take steps to eliminate blinding trachoma by 2020 using the WHO recommended SAFE strategy (surgery of late stage disease, antibiotics for acute infection, and improved facial hygiene and environmental change-ie, improved access to water and sanitation). These developments contributed to the decision by Pfizer Inc to donate azithromycin in support of national programmes implementing SAFE and, with the Edna McConnell Clark Foundation, to found the International Trachoma Initiative as a charity dedicated to the elimination of blinding trachoma by 2020. Reports of the early programme scope and impact are encouraging. In ten national programmes currently underway (constituting about 50% of the global burden) more than 55,000 lid surgeries have halted further corneal damage and prevented blindness, and more than 6 million treatments with azithromycin have been given with reductions in acute infections of around 50% in children. Morocco, one of the first countries to implement SAFE with azithromycin, has achieved remarkable results and expects to eliminate blinding trachoma by 2005. If political will and public-health support can be mobilised, the goal of eliminating this cause of blindness can become a reality by 2020.
Mecaskey
Jeffrey W
JW
International Trachoma Initiative, New York, NY 10017, USA.
Knirsch
Charles A
CA
Kumaresan
Jacob A
JA
Cook
Joseph A
JA
D000349:Africa; D017963:Azithromycin / Q000627:therapeutic use*; D001766:Blindness / Q000209:etiology / Q000517:prevention & control; D002648:Child; D014943:Global Health; D006801:Humans; D006920:Hygiene; D015995:Prevalence; D014141:Trachoma / Q000150:complications / Q000517:prevention & control / Q000635:transmission
D017963:Azithromycin